Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of hepatology"
DOI: 10.1016/j.aohep.2019.04.010
Abstract: INTRODUCTION AND AIMS Cryoglobulinemia is one of the most frequent extrahepatic manifestations of chronic hepatitis C virus (HCV) infection and it may evolve to cryoglobulinemic vasculitis (CryoVas) which is a systemic vasculitis that affects small-sized…
read more here.
Keywords:
cryoglobulinemia;
cryoglobulinemic vasculitis;
cryovas;
prevalence cryoglobulinemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2020.1767586
Abstract: ABSTRACT Introduction Mixed cryoglobulinemia (MC) are immune complexes that can deposit in small and medium size arteries and cause systemic vasculitis called cryoglobulinemic vasculitis (CryoVas). CryoVas most common clinical manifestations include purpura, arthralgia and/or arthritis,…
read more here.
Keywords:
treatment;
strategies prevent;
prevent persistent;
mixed cryoglobulinemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.2324
Abstract: Background In small-size and short term studies of hepatitis C virus (HCV)-cryoglobulinemia vasculitis (CryoVas), direct antiviral agents (DAAs) showed a better response rate and tolerance than interferon containing regimens. Objectives To evaluate the effectiveness and…
read more here.
Keywords:
none declared;
response;
cryoglobulinemia;
consultant ... See more keywords